• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种B细胞淋巴瘤增强主要组织相容性复合体II类肽提呈对Fcγ受体II的依赖性

Fc gamma receptor II dependency of enhanced presentation of major histocompatibility complex class II peptides by a B cell lymphoma.

作者信息

Berg M, Uellner R, Langhorne J

机构信息

Department of Biology, Imperial College of Science, Technology and Medicine, London, GB.

出版信息

Eur J Immunol. 1997 Apr;27(4):1022-8. doi: 10.1002/eji.1830270432.

DOI:10.1002/eji.1830270432
PMID:9130659
Abstract

Here we show that the B cell lymphoma A20.292 is capable of enhanced antigen presentation to CD4+ T cells in the presence of specific antibodies. This enhancement was inhibited by anti-Fc gamma receptor (R) antibodies, suggesting that it might be due to preferential uptake of the antigen/antibody complex through the Fc gamma RII receptor. However, immunoprecipitation studies revealed that the FcR of A20.292 cells was of the B cell type, Fc gamma RIIb1, which is not thought to be able to internalize antigen/antibody complexes via clathrin-coated pits. It was considered unlikely that A20.292 had an altered form of the B cell Fc gamma R (RIIb1) receptor that enabled internalization, since similar enhancing effects were also observed using an Fc gamma RII cell line that had been transfected with Fc gamma RIIb1. To reconcile these findings with the expression of Fc gamma RIIb1, it is postulated that immune complexes are concentrated on the cell surface by the Fc gamma RIIb1 and are thus available for preferential uptake by random fluid-phase endocytosis. This results in more efficient generation of the epitopes recognized by these T cell hybridomas.

摘要

在此我们表明,在存在特异性抗体的情况下,B细胞淋巴瘤A20.292能够增强向CD4+ T细胞的抗原呈递。这种增强作用被抗Fcγ受体(R)抗体所抑制,这表明其可能是由于抗原/抗体复合物通过FcγRII受体的优先摄取。然而,免疫沉淀研究显示,A20.292细胞的FcR属于B细胞类型,即FcγRIIb1,一般认为它无法通过网格蛋白包被小窝内化抗原/抗体复合物。由于使用转染了FcγRIIb1的FcγRII细胞系也观察到了类似的增强作用,所以认为A20.292不太可能具有能实现内化的B细胞FcγR(RIIb1)受体的改变形式。为了使这些发现与FcγRIIb1的表达相协调,推测免疫复合物通过FcγRIIb1在细胞表面浓缩,从而可通过随机液相内吞作用被优先摄取。这导致这些T细胞杂交瘤识别的表位能更有效地产生。

相似文献

1
Fc gamma receptor II dependency of enhanced presentation of major histocompatibility complex class II peptides by a B cell lymphoma.一种B细胞淋巴瘤增强主要组织相容性复合体II类肽提呈对Fcγ受体II的依赖性
Eur J Immunol. 1997 Apr;27(4):1022-8. doi: 10.1002/eji.1830270432.
2
Engagement of the B lymphocyte antigen receptor induces presentation of intrinsic immunoglobulin peptides on major histocompatibility complex class II molecules.B淋巴细胞抗原受体的激活会诱导内在免疫球蛋白肽在主要组织相容性复合体II类分子上的呈递。
Eur J Immunol. 1997 May;27(5):1124-30. doi: 10.1002/eji.1830270512.
3
Tyrosine-containing motif that transduces cell activation signals also determines internalization and antigen presentation via type III receptors for IgG.转导细胞激活信号的含酪氨酸基序还通过IgG的III型受体决定内化作用和抗原呈递。
Nature. 1992 Jul 23;358(6384):337-41. doi: 10.1038/358337a0.
4
Superclustering of B cell receptor and Fc gamma RIIB1 activates Src homology 2-containing protein tyrosine phosphatase-1.B细胞受体和FcγRIIB1的超聚集激活含Src同源2结构域的蛋白酪氨酸磷酸酶-1。
J Immunol. 1998 Sep 15;161(6):2716-22.
5
Functional analysis of human Fc gamma RII (CD32) isoforms expressed in B lymphocytes.在B淋巴细胞中表达的人FcγRII(CD32)亚型的功能分析。
J Immunol. 1994 Jan 15;152(2):574-85.
6
Fc gamma R-mediated endocytosis and expression of cell surface Fc gamma RIIb1 and Fc gamma RIIb2 by mouse bone marrow culture-derived progenitor mast cells.FcγR介导的小鼠骨髓培养来源的祖细胞肥大细胞的内吞作用以及细胞表面FcγRIIb1和FcγRIIb2的表达
J Immunol. 1994 Jan 15;152(2):811-8.
7
Deficient antigen processing of a protein quaternary structure can be overcome by receptor-mediated uptake.
Eur J Immunol. 1993 Dec;23(12):3335-44. doi: 10.1002/eji.1830231241.
8
Fc gamma RII-B1 regulates the presentation of B cell receptor-bound antigens.FcγRII-B1调节B细胞受体结合抗原的呈递。
J Immunol. 1998 Sep 1;161(5):2079-83.
9
Fc gamma RII on human B cells can mediate enhanced antigen presentation.
Cell Immunol. 1996 Feb 1;167(2):188-94. doi: 10.1006/cimm.1996.0026.
10
Efficiency of antigen presentation after antigen targeting to surface IgD, IgM, MHC, Fc gamma RII, and B220 molecules on murine splenic B cells.抗原靶向小鼠脾脏B细胞表面的IgD、IgM、MHC、FcγRII和B220分子后抗原呈递的效率。
J Immunol. 1989 Jul 1;143(1):59-65.

引用本文的文献

1
Augmenting Vaccine Immunogenicity through the Use of Natural Human Anti-rhamnose Antibodies.通过使用天然人抗鼠李糖抗体增强疫苗免疫原性。
ACS Chem Biol. 2018 Aug 17;13(8):2130-2142. doi: 10.1021/acschembio.8b00312. Epub 2018 Jul 2.
2
Identification of critical residues of linear B cell epitope on Goodpasture autoantigen.鉴定Goodpasture自身抗原线性B细胞表位的关键残基。
PLoS One. 2015 Apr 13;10(4):e0123277. doi: 10.1371/journal.pone.0123277. eCollection 2015.
3
Human monoclonal antibodies targeting nonoverlapping epitopes on insulin-like growth factor II as a novel type of candidate cancer therapeutics.
针对胰岛素样生长因子 II 上非重叠表位的人源单克隆抗体作为一种新型候选癌症治疗药物。
Mol Cancer Ther. 2012 Jul;11(7):1400-10. doi: 10.1158/1535-7163.MCT-12-0172. Epub 2012 May 2.
4
Dendritic cells, but not macrophages or B cells, activate major histocompatibility complex class II-restricted CD4+ T cells upon immune-complex uptake in vivo.在体内摄取免疫复合物后,树突状细胞而非巨噬细胞或B细胞可激活主要组织相容性复合体II类限制性CD4 + T细胞。
Immunology. 2006 Dec;119(4):499-506. doi: 10.1111/j.1365-2567.2006.02464.x. Epub 2006 Sep 21.
5
Specific antigen targeting to surface IgE and IgG on mouse bone marrow-derived mast cells enhances efficiency of antigen presentation.靶向小鼠骨髓来源肥大细胞表面IgE和IgG的特异性抗原可提高抗原呈递效率。
Immunology. 1998 Jul;94(3):318-24. doi: 10.1046/j.1365-2567.1998.00525.x.